OPTICAL CABLE CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OPTICAL CABLE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | $20.27M | Dec 19, 2018 |
| FY2018 | Jul 31, 2018 | $23.12M | Dec 19, 2018 |
| FY2018 | Apr 30, 2018 | $26.89M | Dec 19, 2018 |
| FY2018 | Jan 31, 2018 | $17.55M | Dec 19, 2018 |
| FY2018 | Oct 31, 2017 | $17.21M | Dec 19, 2018 |
| FY2018 | Jul 31, 2017 | $16.43M | Dec 19, 2018 |
| FY2018 | Apr 30, 2017 | $15.85M | Dec 19, 2018 |
| FY2018 | Jan 31, 2017 | $14.61M | Dec 19, 2018 |
| FY2018 | Oct 31, 2016 | $64.62M | Dec 19, 2018 |
| FY2013 | Oct 31, 2013 | $10.60M | Dec 20, 2013 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $17.21M | Dec 20, 2017 |
| FY2017 | Jul 31, 2017 | $16.43M | Dec 20, 2017 |
| FY2017 | Apr 30, 2017 | $15.85M | Dec 20, 2017 |
| FY2017 | Jan 31, 2017 | $14.61M | Dec 20, 2017 |
| FY2017 | Oct 31, 2016 | $17.31M | Dec 20, 2017 |
| FY2017 | Jul 31, 2016 | $16.92M | Dec 20, 2017 |
| FY2017 | Apr 30, 2016 | $16.34M | Dec 20, 2017 |
| FY2017 | Jan 31, 2016 | $14.05M | Dec 20, 2017 |
| FY2016 | Oct 31, 2015 | $16.75M | Dec 20, 2016 |
| FY2016 | Jul 31, 2015 | $20.78M | Dec 20, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $6.32M | Dec 18, 2025 |
| FY2025 | Jul 31, 2025 | $6.32M | Dec 18, 2025 |
| FY2025 | Apr 30, 2025 | $5.33M | Dec 18, 2025 |
| FY2025 | Jan 31, 2025 | $4.63M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $6.53M | Dec 18, 2025 |
| FY2025 | Jul 31, 2024 | $3.92M | Dec 18, 2025 |
| FY2025 | Apr 30, 2024 | $4.04M | Dec 18, 2025 |
| FY2025 | Jan 31, 2024 | $3.71M | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $3.87M | Dec 23, 2024 |
| FY2024 | Jul 31, 2023 | $5.12M | Dec 23, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $48.6K | Dec 18, 2025 |
| FY2025 | Jul 31, 2025 | $301.9K | Dec 18, 2025 |
| FY2025 | Apr 30, 2025 | ($697.9K) | Dec 18, 2025 |
| FY2025 | Jan 31, 2025 | ($1.11M) | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $373.5K | Dec 18, 2025 |
| FY2025 | Jul 31, 2024 | ($1.56M) | Dec 18, 2025 |
| FY2025 | Apr 30, 2024 | ($1.60M) | Dec 18, 2025 |
| FY2025 | Jan 31, 2024 | ($1.43M) | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | ($1.27M) | Dec 23, 2024 |
| FY2024 | Jul 31, 2023 | $100.8K | Dec 23, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $268.7K | Dec 18, 2025 |
| FY2025 | Jul 31, 2025 | $562.5K | Dec 18, 2025 |
| FY2025 | Apr 30, 2025 | ($429.2K) | Dec 18, 2025 |
| FY2025 | Jan 31, 2025 | ($852.4K) | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $662.1K | Dec 18, 2025 |
| FY2025 | Jul 31, 2024 | ($1.34M) | Dec 18, 2025 |
| FY2025 | Apr 30, 2024 | ($1.30M) | Dec 18, 2025 |
| FY2025 | Jan 31, 2024 | ($1.40M) | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | ($1.29M) | Dec 23, 2024 |
| FY2024 | Jul 31, 2023 | $138.4K | Dec 23, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Oct 31, 2015 | $1.30M | Jan 28, 2016 |
| FY2015 | Oct 31, 2014 | $1.40M | Jan 28, 2016 |
| FY2015 | Oct 31, 2013 | $1.40M | Jan 28, 2016 |
| FY2014 | Oct 31, 2012 | $1.30M | Dec 19, 2014 |
| FY2013 | Oct 31, 2011 | $1.10M | Dec 20, 2013 |
| FY2012 | Oct 31, 2010 | $1.00M | Dec 21, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $6.03M | Dec 18, 2025 |
| FY2025 | Jul 31, 2025 | $5.74M | Dec 18, 2025 |
| FY2025 | Apr 30, 2025 | $5.74M | Dec 18, 2025 |
| FY2025 | Jan 31, 2025 | $5.46M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $5.85M | Dec 18, 2025 |
| FY2025 | Jul 31, 2024 | $5.24M | Dec 18, 2025 |
| FY2025 | Apr 30, 2024 | $5.32M | Dec 18, 2025 |
| FY2025 | Jan 31, 2024 | $5.09M | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $5.15M | Dec 23, 2024 |
| FY2024 | Jul 31, 2023 | $4.96M | Dec 23, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.41M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | ($857.0K) | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | ($395.7K) | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | ($1.49M) | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | ($1.59M) | Dec 20, 2023 |
| FY2023 | Apr 30, 2022 | ($3.03M) | Jun 12, 2023 |
| FY2023 | Oct 31, 2021 | $2.12M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | ($3.55M) | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | ($283.8K) | Dec 20, 2021 |
| FY2020 | Oct 31, 2018 | $3.21M | Dec 21, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $295.5K | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $369.6K | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $520.8K | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | $230.3K | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | $279.8K | Dec 20, 2023 |
| FY2023 | Apr 30, 2022 | $100.3K | Jun 12, 2023 |
| FY2023 | Oct 31, 2021 | $166.2K | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $120.0K | Dec 22, 2022 |
| FY2021 | Oct 31, 2019 | $487.6K | Dec 20, 2021 |
| FY2020 | Oct 31, 2018 | $688.9K | Dec 21, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $40.06M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $40.36M | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $43.88M | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | $45.98M | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | $40.56M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $37.92M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $36.56M | Dec 20, 2021 |
| FY2020 | Oct 31, 2019 | $40.11M | Dec 21, 2020 |
| FY2019 | Oct 31, 2018 | $43.10M | Jan 27, 2020 |
| FY2018 | Oct 31, 2017 | $40.14M | Dec 19, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $18.49M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $19.52M | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $19.16M | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | $20.41M | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | $18.40M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $15.71M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $21.30M | Dec 20, 2021 |
| FY2020 | Oct 31, 2019 | $18.87M | Dec 21, 2020 |
| FY2019 | Oct 31, 2018 | $16.29M | Jan 27, 2020 |
| FY2018 | Oct 31, 2017 | $16.45M | Dec 19, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $16.51M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $20.84M | Dec 18, 2025 |
| FY2025 | Oct 31, 2023 | $24.72M | Dec 18, 2025 |
| FY2023 | Apr 30, 2023 | $25.57M | Jun 12, 2023 |
| FY2023 | Jan 31, 2023 | $23.00M | Jun 12, 2023 |
| FY2024 | Oct 31, 2022 | $22.16M | Dec 23, 2024 |
| FY2023 | Apr 30, 2022 | $21.18M | Jun 12, 2023 |
| FY2023 | Jan 31, 2022 | $21.29M | Jun 12, 2023 |
| FY2023 | Oct 31, 2021 | $22.21M | Dec 20, 2023 |
| FY2023 | Oct 31, 2020 | $15.26M | Dec 20, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $763.2K | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $5.38M | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $9.59M | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | $10.75M | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | $7.52M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $7.87M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $1.26M | Dec 20, 2021 |
| FY2020 | Oct 31, 2019 | $7.39M | Dec 21, 2020 |
| FY2019 | Oct 31, 2018 | $12.99M | Jan 27, 2020 |
| FY2018 | Oct 31, 2017 | $11.93M | Dec 19, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $237.5K | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | $244.2K | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | $1.47M | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | $325.0K | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | $215.9K | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $132.2K | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $140.8K | Dec 20, 2021 |
| FY2020 | Oct 31, 2019 | $537.3K | Dec 21, 2020 |
| FY2019 | Oct 31, 2018 | $177.4K | Jan 27, 2020 |
| FY2019 | Oct 31, 2017 | $891.2K | Jan 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Oct 31, 2023 | $2.68M | Dec 20, 2023 |
| FY2023 | Apr 30, 2023 | $4.36M | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | $4.53M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $4.85M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | $5.17M | Dec 20, 2021 |
| FY2020 | Oct 31, 2019 | $5.91M | Dec 21, 2020 |
| FY2019 | Oct 31, 2018 | $6.42M | Jan 27, 2020 |
| FY2018 | Oct 31, 2017 | $6.67M | Dec 19, 2018 |
| FY2017 | Oct 31, 2016 | $6.95M | Dec 20, 2017 |
| FY2016 | Oct 31, 2015 | $7.23M | Dec 20, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 0 | Dec 18, 2025 |
| FY2025 | Jul 31, 2025 | 0 | Dec 18, 2025 |
| FY2025 | Apr 30, 2025 | 0 | Dec 18, 2025 |
| FY2025 | Jan 31, 2025 | 0 | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | 0 | Dec 18, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Dec 18, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Dec 18, 2025 |
| FY2025 | Jan 31, 2024 | 0 | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | 0 | Dec 23, 2024 |
| FY2024 | Jul 31, 2023 | 0 | Dec 23, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Oct 31, 2012 | 0 | Dec 21, 2012 |
| FY2012 | Oct 31, 2011 | 0 | Dec 21, 2012 |
| FY2012 | Oct 31, 2010 | 0 | Dec 21, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 8.23M | Dec 18, 2025 |
| FY2025 | Oct 31, 2024 | 8.22M | Dec 18, 2025 |
| FY2024 | Oct 31, 2023 | 7.89M | Dec 23, 2024 |
| FY2023 | Apr 30, 2023 | 7.87M | Jun 12, 2023 |
| FY2023 | Oct 31, 2022 | 7.89M | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | 7.90M | Dec 22, 2022 |
| FY2021 | Oct 31, 2020 | 7.54M | Dec 20, 2021 |
| FY2020 | Oct 31, 2019 | 7.46M | Dec 21, 2020 |
| FY2019 | Oct 31, 2018 | 7.69M | Jan 27, 2020 |
| FY2018 | Oct 31, 2017 | 7.32M | Dec 19, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2016 | $141.3K | Dec 19, 2018 |
| FY2017 | Oct 31, 2015 | $555.6K | Dec 20, 2017 |
| FY2016 | Oct 31, 2014 | $540.0K | Dec 20, 2016 |
| FY2015 | Oct 31, 2013 | $479.1K | Jan 28, 2016 |
| FY2014 | Oct 31, 2012 | $357.1K | Dec 19, 2014 |
| FY2013 | Oct 31, 2011 | $252.0K | Dec 20, 2013 |